Prostate Cancer

The CyberKnife® robotic radiosurgery system is a widely used form of nonsurgical prostate stereotactic body radiation therapy (SBRT). The American Society for Radiation Oncology (ASTRO) believes that enough clinical evidence exists so that SBRT should be considered an appropriate treatment option for select patients with low- to intermediate-risk prostate cancer. CyberKnife is designed to avoid healthy tissue and critical anatomy, therefore reducing side effects such as erectile dysfunction, urinary and bowel complications.

Clinical Trials & Research

Treatment Comparison

CyberKnife®

  • Noninvasive, no incisions
  • Continue daily activities
  • No hospitalization or anesthesia
  • No catheter needed
  • Painless
  • 5 outpatient sessions
  • Little or no recovery time
  • Minimal side effects

Conventional Radiation

  • Used to be standard of care alternative to surgery
  • Equivalent outcomes to surgery and CyberKnife
  • Equivalent side effects to surgery and CyberKnife
  • Daily treatment for 9 weeks
  • No hospital stay or catheter

Robotic Surgery

  • Used to be standard of care for young men
  • Robotic surgery requires shorter hospital stay
  • Recovery Period
    • One week before driving
    • Three weeks to return to work
    • Six weeks to normal daily activities
  • Catheter required for shorter time
  • Outcomes equivalent to CyberKnife and Radiation
  • Side effects equivalent to Cyberknife and Radiation

Talk to a team member

Our physicians and team are on call to help evaluate the best options for you! Contact us today!

(610) 446-6850

Important Patient Questions

Lorem ipsum dolor sit amet, ut labore sanctus vis, est populo utroque iracundia ne, at novum consul eos. Laoreet ponderum repudiare ad duo, ne ceteros officiis lucilius vel, te nam possim iracundia.

Lorem ipsum dolor sit amet, ut labore sanctus vis, est populo utroque iracundia ne, at novum consul eos. Laoreet ponderum repudiare ad duo, ne ceteros officiis lucilius vel, te nam possim iracundia.

Lorem ipsum dolor sit amet, ut labore sanctus vis, est populo utroque iracundia ne, at novum consul eos. Laoreet ponderum repudiare ad duo, ne ceteros officiis lucilius vel, te nam possim iracundia.

Lorem ipsum dolor sit amet, ut labore sanctus vis, est populo utroque iracundia ne, at novum consul eos. Laoreet ponderum repudiare ad duo, ne ceteros officiis lucilius vel, te nam possim iracundia.

Lorem ipsum dolor sit amet, ut labore sanctus vis, est populo utroque iracundia ne, at novum consul eos. Laoreet ponderum repudiare ad duo, ne ceteros officiis lucilius vel, te nam possim iracundia.

Lorem ipsum dolor sit amet, ut labore sanctus vis, est populo utroque iracundia ne, at novum consul eos. Laoreet ponderum repudiare ad duo, ne ceteros officiis lucilius vel, te nam possim iracundia.

Follow Us